Determination of Genotoxic Azide Impurity in Cilostazol API by Ion Chromatography with Matrix Elimination
Cilostazol is a commonly used active pharmaceutical ingredient (API) to treat and reduce the symptoms of intermittent claudication in peripheral vascular disease. Recently, it was found to be a potential medicine in the effective treatment of COVID-19. In addition to the positive effects of this API...
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
MDPI AG
2021-09-01
|
| Colecção: | Separations |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2297-8739/8/10/162 |